Scott Thomas Jackson
CIK 1566617 · Chief Executive Officer · last filed 2026-06-25
Scott Thomas Jackson is a Chief Executive Officer who has filed 41 SEC Form 4 insider transactions across 5 companies since 2013. The most recent filing, for SPRO, was dated Jun 25, 2026. Across all open-market trades the lifetime net is +$57.6K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $166.7K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$166.7K
5
41
$57.6K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SPRO | Director | 85,000 | $1.26 | $107.1K | $0 | 8 | 2026-06-25 |
| MGNX | Director | 14,750 | $4.04 | $59.6K | $0 | 12 | 2026-05-20 |
| MURAV | Director | — | — | — | $0 | 5 | 2025-12-05 |
| CRESCENT BIOPHARMA, INC. (GLYC) Delisted | Director | 52 | $15.70 | $816 | $0 | 7 | 2024-05-01 |
| Celator Pharmaceuticals Inc (CPXX) Delisted | Chief Executive Officer | 0 | — | — | $57.6K | 8 | 2016-07-12 |
Recent Filings
41 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-25 | SPRO | Grant (A) | +10,000 | $0 | EDGAR |
| 2026-05-20 | MGNX | Mixed | +3,750 | $0 | EDGAR |
| 2025-12-05 | MURAV | Disp (D) | — | $0 | EDGAR |
| 2025-06-16 | SPRO | Grant (A) | +20,000 | $0 | EDGAR |
| 2025-06-13 | MURAV | Grant (A) | — | $0 | EDGAR |
| 2025-05-22 | MGNX | Mixed | +6,500 | $0 | EDGAR |
| 2024-06-05 | MURAV | Grant (A) | — | $0 | EDGAR |
| 2024-06-03 | MURAV | Grant (A) | — | $0 | EDGAR |
| 2024-05-30 | SPRO | Grant (A) | +20,000 | $0 | EDGAR |
| 2024-05-23 | MGNX | Grant (A) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.